Document:

vitl-ex103_124.htm

 

Exhibit 10.3

VITAL FARMS, INC.

CHANGE IN CONTROL SEVERANCE PLAN

AND

SUMMARY PLAN DESCRIPTION

 

APPROVED BY THE COMPENSATION COMMITTEE: MARCH 31, 2022

1.Introduction.  The purpose of this Vital Farms, Inc. Change in Control Severance Plan (the “Plan”) is to provide assurances of specified severance benefits to eligible executives of the Company whose employment with the Company or a successor is terminated under certain circumstances.  This Plan is an “employee welfare benefit plan,” as defined in Section 3(1) of ERISA (as defined below).  This Plan shall supersede any individual agreement between the Company and any Covered Employee (as defined below) and any other plan, policy or practice, whether written or unwritten, maintained by the Company with respect to a Covered Employee, in each case, to the extent that such agreement, plan, policy or practice provides for equity acceleration or severance benefits upon the Covered Employee’s separation from the Company.  This document constitutes both the written instrument under which the Plan is maintained and the required summary plan description for the Plan. 

2.Definitions.  For purposes of the Plan, the terms below are defined as follows: 

2.1.“Administrator” means the Board or Compensation Committee prior to a Change in Control; or, after a Change in Control, one or more members of the successor Board or Compensation Committee or other persons designated by the Company’s Board or Compensation Committee prior to such Change in Control.

2.2.“Annual Bonus Program” means the annual performance bonus or other variable compensation program under which the Covered Employee would be eligible to earn a Full Bonus, Pro-Rated Bonus or Target Bonus, as applicable.

2.3.“Board” means the Board of Directors of the Company.

2.4.“Cause” means with respect to such Covered Employee, the occurrence of any of the following events: (i) such Covered Employee’s material failure to follow any proper and lawful directive of the Board that remains uncured more than thirty (30) days after a written demand is delivered to such Covered Employee that specifically identifies the manner in which the Board believes that such Covered Employee has failed to follow such instructions, provided, that failure to meet performance targets shall not, in and of itself, be deemed a failure to follow any such instructions; (ii) such Covered Employee’s commission of an act of: (a) fraud, embezzlement, or theft; or (b) dishonesty that injures the business, business reputation or business relationships of the Company; (iii) such Covered Employee’s commission or conviction of, or pleading guilty or nolo contendere to, a felony; and (iv) such Covered Employee’s material violation of any agreement between such Covered Employee and Company or of any material Company policy that remains uncured (if curable) more than thirty (30) days after written notice thereof is delivered to such Covered Employee that specifically identities such violation.  The determination of whether a termination is for Cause shall be made by the Administrator in its sole and exclusive judgment and discretion. 

2.5.“Change in Control” has the meaning ascribed to such term in the Stock Plan.

2.6.“Change in Control Period” means the time period beginning on the date on which a Change in Control becomes effective and ending on the first anniversary of the effective date of such Change in Control (except as otherwise set forth in a Participation Agreement). 

2.7.“COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.

2.8.“Code” means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.

2.9.“Company” means Vital Farms, Inc. and any successor. 

2.10.“Compensation Committee” means the Compensation Committee of the Board.

2.11.“Covered Employee” means an employee of the Company who (i) has been designated by the Administrator to participate in the Plan, (ii) has executed the Company’s standard confidentially and inventions assignment agreement, and (iii) has timely and properly executed and delivered a Participation Agreement to the Company.

2.12.“Covered Termination” means a Covered Employee’s termination of employment by the Company (or any parent or subsidiary of the Company) without Cause or as a result of the Covered Employee’s resignation for Good Reason; provided, that, in either case, such termination is not due to the Covered Employee’s death or Disability.

2.13.“Death/Disability Termination” means a Covered Employee’s termination of employment due to the Covered Employee’s death or Disability.

2.14.“Disability” means a physical or mental illness, impairment or infirmity (other than an absence from work on an approved maternity or paternity leave) that renders the Covered Employee unable to perform the essential functions of the Covered Employee, including the duties of the Covered Employee under the Covered Employee’s employment agreement with the Company, with reasonable accommodation, as determined by a physician selected by the Company and acceptable to the Covered Employee or the legal representative of the Covered Employee, for at least ninety (90) days during any 365-consecutive-day period.

2.15.“Effective Date” means the date on which the Plan is approved by the Compensation Committee.

2.16.“ERISA” means the Employee Retirement Income Security Act of 1974, as amended. 

2.17.“Full Bonus” means a cash amount equal to the annual bonus otherwise payable to the Covered Employee based on actual performance pursuant to any Annual Bonus Program in which the Covered Employee participated for the most recent completed fiscal year ending prior to the Covered Employee’s Covered Termination, Death/Disability Termination or Retirement, as applicable.

2.18.“Good Reason” means with respect to such Covered Employee, any of the following conditions or actions taken by the Company without Cause and without such Covered Employee’s consent: (i) a material  breach by the Company of an agreement between such Covered Employee and the Company; (ii) the  Company materially reduces such Covered Employee’s base salary or the target percentage eligibility established for such Covered Employee’s annual bonus, in either case 

2

 

by 10%, other than any Company-wide reduction in compensation of employees; (iii) the Company materially reduces such Covered Employee’s duties, authority or responsibilities relative to such Covered Employee’s duties, authority or responsibilities in effect immediately prior to such reduction provided, however, that the mere conversion of the Company to a subsidiary, division or unit of an acquiring entity in connection with a Change in Control, or a change in the Covered Employee’s reporting relationships or title following a Change in Control, will not be deemed a material diminution in and of itself; or (iv) the Company relocates the facility that is such Covered  Employee’s principal place of business with the Company to a location more than fifty (50) miles from  the immediately preceding location (excluding regular travel in the ordinary course of business); provided, further, that in each case above, in order for the Covered Employee’s resignation to be deemed to have been for Good Reason, the Covered Employee must first give the Company written notice of the action or omission giving rise to “Good Reason” within thirty (30) days after the first occurrence thereof; the Company must fail to reasonably cure such action or omission within thirty (30) days after receipt of  such notice (the “Cure Period”), and the Covered Employee’s resignation must be effective not later than  thirty (30) days after the expiration of such Cure Period.

2.19.“Participation Agreement” means an agreement between a Covered Employee and the Company in substantially the form of Appendix A attached hereto, and which may include such other terms as the Administrator deems necessary or advisable in the administration of the Plan.

2.20.“Pro-Rated Bonus” means a cash amount equal to either (i) in the case of a Covered Termination during the Change in Control Period, the Covered Employee’s Target Bonus, or (ii) in the case of a Death/Disability Termination or Retirement, the Covered Employee’s annual bonus earned based on actual performance; in each case (i) or (ii), with respect to the annual bonus otherwise payable under the Annual Bonus Program for the fiscal year in which the Covered Employee’s termination of employment occurred and pro-rated for the Covered Employee’s months of service during the applicable fiscal year, up to and including the month of termination.

2.21.“Retirement” means a voluntary resignation by the Covered Employee at or after the age of 60 following continuous employment by the Company (or successor to the Company, if applicable) for a period of at least ten years, with at least 120 days’ notice by the Covered Employee to the Company (or successor to the Company, if applicable) of such voluntary resignation.

2.22.“Severance Benefits” means the compensation and other benefits the Covered Employee will be provided pursuant to Section 4. 

2.23.“Stock Plan” means the Company’s 2020 Equity Incentive Plan, as amended or amended and restated from time to time, or any successor thereto.

2.24.“Termination Date” means the Covered Employee’s last day of employment with the Company.

2.25.“Target Bonus” means the Covered Employee’s target annual bonus under the Annual Bonus Program. If the Covered Employee is eligible for a target annual bonus for the fiscal year in which the Covered Termination occurs, but the target percentage (or target dollar amount, if specified as such in the applicable bonus plan) for such bonus has not yet been established for such fiscal year, the target percentage shall be the target percentage established for the Covered Employee for the preceding fiscal year (but adjusted, if necessary for the Covered Employee’s position for the fiscal year in which the Covered Termination occurs).  For the avoidance of doubt, the “Target Bonus” amount will be calculated (1) assuming all articulated performance goals for such bonus (including, but not limited to, corporate and individual performance, if applicable), for the fiscal year of the Covered Termination were achieved at 

3

 

target levels; (2) as if the Covered Employee had provided services for the entire fiscal year for which the bonus relates; and (3) ignoring any reduction in the Covered Employee’s base salary that would give rise to the Covered Employee’s right to resignation for Good Reason.

3.Eligibility for Severance Benefits.  An individual is eligible for severance benefits under the Plan, in the amounts set forth in Section 4, only if such individual is a Covered Employee on the date such individual experiences a Covered Termination or Death/Disability Termination or such individual’s employment with the Company is terminated due to Retirement.

4.Severance Benefits. 

4.1.Covered Termination Outside the Change in Control Period.  If, at any time outside of the Change in Control Period, a Covered Employee experience a Covered Termination, then, subject to the Covered Employee’s compliance with Section 5, the Covered Employee shall receive the following Severance Benefits from the Company (the “Standard Severance Benefits”): 

4.1.1.Base Salary.  The Covered Employee shall receive cash severance in an amount equal to the Covered Employee’s annual base salary (as in effect immediately prior to any reduction giving rise to Good Reason, if applicable) for the number of months set forth in the Covered Employee’s Participation Agreement (the “Standard Severance Period”).  The cash amount shall be paid, less applicable tax withholdings, in equal installments on the Company’s regular payroll schedule during the period commencing on the date of the Covered Termination and continuing through the Standard Severance Period, provided, that no payment shall be made prior to the first payroll date following the effective date of the Release in accordance with Section 5 (the “Initial Payment Date”).  On the Initial Payment Date, the Company shall pay the Covered Employee in a lump sum the cash amount that the Covered Employee would have received on or prior to the Initial Payment Date under the original schedule but for the delay while waiting for Initial Payment Date in compliance with Section 409A (as defined below) and the effectiveness of the Release, with the balance of the cash amount being paid as originally scheduled.  Notwithstanding the foregoing, the Company, in its sole and absolute discretion, may pay the cash amount in the form of a lump sum, which amount will be paid on the Initial Payment Date, but such lump sum payment shall be made only if the Company, in consultation with its advisors, determines that such payment will not result in adverse taxation under Section 409A.

4.1.2.Full Bonus.  To the extent not already paid to the Covered Employee, the Covered Employee will additionally be eligible to receive the Full Bonus, which shall be paid, less applicable tax withholdings, in a lump sum cash payment concurrently with the annual cash bonus payments to other similarly-situated employees, provided, that no payment shall be made prior to the Initial Payment Date, but that such payment shall in any event be made prior to March 15 of the year following the year of the Covered Employee's termination.

4.1.3.COBRA Premiums.  Provided the Covered Employee is eligible for and timely makes the necessary elections for continuation coverage pursuant to COBRA the Company shall pay the applicable premiums (inclusive of premiums for the Covered Employee’s dependents) for such coverage following the date of the Covered Employee’s Covered Termination for the Standard Severance Period (such period of months, the “Standard COBRA Payment Period”) (but in no event after such time as the Covered Employee is eligible for coverage under a health, dental or vision insurance plan of a subsequent employer or as the Covered Employee and the Covered Employee’s dependents are no longer eligible for COBRA coverage).  The Covered Employee shall notify the Company immediately if the Covered Employee becomes covered by a health, dental, or vision insurance plan of a subsequent employer or if the Covered Employee’s dependents are no longer eligible for COBRA coverage.  Notwithstanding the foregoing, if at any time the Company determines, in its sole and absolute discretion, that it cannot 

4

 

provide the COBRA premium benefits without potentially incurring financial costs or penalties under applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then in lieu of paying COBRA premiums on the Covered Employee’s behalf, the Company will instead pay such Covered Employee on the last day of each remaining month of the Standard COBRA Payment Period a fully taxable cash payment equal to the COBRA premium for that month, subject to applicable tax withholding (such amount, the “Special Severance Payment”), such Special Severance Payment to be made without regard to the Covered Employee’s election of COBRA coverage or payment of COBRA premiums and without regard to such Covered Employee’s continued eligibility for COBRA coverage during the Standard COBRA Payment Period; provided, however, that such Special Severance Payment shall end upon expiration of the Standard COBRA Payment Period.

4.1.4.Post-Termination Exercisability Period for Outstanding Vested Stock Options.  The Covered Employee shall have three (3) months following the date of the Covered Employee’s Covered Termination in which to exercise the outstanding and vested stock options held by the Covered Employee as of the date of the Covered Employee’s Covered Termination that are granted on or after the Effective Date, notwithstanding the terms of the individual grant notice and award agreement evidencing such awards; provided, however, that in no event will the Covered Employee’s stock options be permitted to be exercised beyond their original maximum term to expiration.

4.2.Covered Termination During the Change in Control Period.  If, at any time during the Change in Control Period, a Covered Employee experiences a Covered Termination, then, subject to the Covered Employee’s compliance with Section 5, the Covered Employee shall receive the following Severance Benefits from the Company (the “CIC Severance Benefits”): 

4.2.1.Base Salary; Target Bonus.  The Covered Employee shall receive cash severance in an amount equal to the sum of (i) the Covered Employee’s annual base salary (as in effect immediately prior to any reduction giving rise to Good Reason, if applicable) for the number of months set forth in the Covered Employee’s Participation Agreement (the “CIC Severance Period”) and (ii) only to the extent set forth in the Covered Employee’s Participation Agreement, the Target Bonus.  The cash amount shall be paid, less applicable tax withholdings, in equal installments on the Company’s regular payroll schedule during the period commencing on the date of the Covered Termination and continuing through the CIC Severance Period, provided, that no payment shall be made prior to the Initial Payment Date.  On the Initial Payment Date, the Company shall pay the Covered Employee in a lump sum the cash amount that the Covered Employee would have received on or prior to the Initial Payment Date under the original schedule but for the delay while waiting for Initial Payment Date in compliance with Section 409A (as defined below) and the effectiveness of the Release, with the balance of the cash amount being paid as originally scheduled.  Notwithstanding the foregoing, the Company, in its sole and absolute discretion, may pay the cash amount in the form of a lump sum, which amount will be paid on the Initial Payment Date, but such lump sum payment shall be made only if the Company, in consultation with its advisors, determines that such payment will not result in adverse taxation under Section 409A.

4.2.2.Full Bonus.  To the extent not already paid to the Covered Employee, the Covered Employee will additionally be eligible to receive the Full Bonus, which shall be paid, less applicable tax withholdings, in a lump sum cash payment concurrently with the annual cash bonus payments to other similarly-situated employees, provided, that no payment shall be made prior to the Initial Payment Date, but that such payment shall in any event be made prior to March 15 of the year following the year of the Covered Employee's termination. 

4.2.3.Pro-Rated Bonus.  The Covered Employee will additionally be eligible to receive the Pro-Rated Bonus, which shall be paid, less applicable tax withholdings, in a lump sum cash payment on the Initial Payment Date. 

5

 

4.2.4.COBRA Premiums.  Provided the Covered Employee is eligible for and timely makes the necessary elections for continuation coverage pursuant to COBRA the Company shall pay the applicable premiums (inclusive of premiums for the Covered Employee’s dependents) for such coverage following the date of the Covered Employee’s Covered Termination for up to the CIC Severance Period (such period of months, the “CIC COBRA Payment Period”) (but in no event after such time as the Covered Employee is eligible for coverage under a health, dental or vision insurance plan of a subsequent employer or as the Covered Employee and the Covered Employee’s dependents are no longer eligible for COBRA coverage).  The Covered Employee shall notify the Company immediately if the Covered Employee becomes covered by a health, dental, or vision insurance plan of a subsequent employer or if the Covered Employee’s dependents are no longer eligible for COBRA coverage.  Notwithstanding the foregoing, if at any time the Company determines, in its sole and absolute discretion, that it cannot provide the COBRA premium benefits without potentially incurring financial costs or penalties under applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then in lieu of paying COBRA premiums on the Covered Employee’s behalf, the Company will instead pay such Covered Employee on the last day of each remaining month of the CIC COBRA Payment Period a Special Severance Payment to be made without regard to the Covered Employee’s election of COBRA coverage or payment of COBRA premiums and without regard to such Covered Employee’s continued eligibility for COBRA coverage during the CIC COBRA Payment Period; provided, however, that such Special Severance Payment shall end upon expiration of the CIC COBRA Payment Period.

4.2.5.Equity Vesting.  Each of the Covered Employee’s then outstanding equity awards, including awards that would otherwise vest only upon satisfaction of performance criteria, shall accelerate and become vested and exercisable as to 100% of the unvested shares subject to the equity award, except any award granted after the Effective Date that explicitly overrides this provision in writing.  Subject to the Covered Employee’s compliance with Section 5, the accelerated vesting described in this paragraph shall be effective as of the Termination Date.  For purposes of this Section 4.2.5, any equity awards subject to performance-based vesting shall accelerate based on target performance.  Notwithstanding anything herein to the contrary, nothing in the Plan shall limit the Company’s ability to accelerate vesting and/or exercisability of outstanding equity awards pursuant to the terms of the applicable equity incentive plan of the Company.  In order to give effect to the intent of the foregoing provision, notwithstanding anything to the contrary set forth in the applicable equity incentive plan of the Company or the applicable equity award agreements that provide that any then unvested portion of the Covered Employee’s award will immediately expire upon such Covered Employee’s termination of service, such Covered Employee’s equity awards shall remain outstanding following such Covered Employee’s Covered Termination to give effect to such acceleration as necessary.

4.2.6.Post-Termination Exercisability Period for Outstanding Vested Stock Options.  The Covered Employee shall have three (3) months following the date of the Covered Employee’s Covered Termination in which to exercise the outstanding and vested stock options held by the Covered Employee as of the date of the Covered Employee’s Covered Termination that are granted on or after the Effective Date (including, but not limited to, any such stock options that become vested in accordance with Section 4.2.5); provided, however, that in no event will the Covered Employee’s stock options be permitted to be exercised beyond their original maximum term to expiration.

4.3.Death/Disability Termination.  If a Covered Employee experiences a Death/Disability Termination, then, subject to the Covered Employee’s compliance with Section 5, the Covered Employee (or the Covered Employee’s estate, as applicable) shall receive the following Severance Benefits from the Company:

4.3.1.Full Bonus.  To the extent not already paid to the Covered Employee, the Covered Employee will additionally be eligible to receive the Full Bonus, which shall be paid, less 

6

 

applicable tax withholdings, in a lump sum cash payment  concurrently with the annual cash bonus payments to other similarly-situated employees, provided, that no payment shall be made prior to the Initial Payment Date, but that such payment shall in any event be made prior to March 15 of the year following the year of the Covered Employee's termination.

4.3.2.Pro-Rated Bonus.  The Covered Employee will be eligible to receive the Pro-Rated Bonus, less applicable tax withholdings, which shall be payable to the Covered Employee in a lump sum cash payment concurrently with the annual cash bonus payments to other similarly-situated employees under the Annual Bonus Program, provided, that no payment shall be made prior to the Initial Payment Date, but that such payment shall in any event be made prior to March 15 of the year following the year of the Covered Employee's termination.

4.3.3.Equity Vesting.  Each of the Covered Employee’s then outstanding equity awards, including awards that would otherwise vest only upon satisfaction of performance criteria, shall accelerate and become vested and exercisable as to 100% of the unvested shares subject to the equity award, except any award granted after the Effective Date that explicitly overrides this provision in writing.  Subject to the Covered Employee’s compliance with Section 5, the accelerated vesting described in this paragraph shall be effective as of the Termination Date.  For purposes of this Section 4.3.3, any equity awards subject to performance-based vesting shall accelerate based on target performance.  Notwithstanding anything herein to the contrary, nothing in the Plan shall limit the Company’s ability to accelerate vesting and/or exercisability of outstanding equity awards pursuant to the terms of the applicable equity incentive plan of the Company.  In order to give effect to the intent of the foregoing provision, notwithstanding anything to the contrary set forth in the applicable equity incentive plan of the Company or the applicable equity award agreements that provide that any then unvested portion of the Covered Employee’s award will immediately expire upon such Covered Employee’s termination of service, such Covered Employee’s equity awards shall remain outstanding following such Covered Employee’s Death/Disability Termination to give effect to such acceleration as necessary. 

4.3.4.Post-Termination Exercisability Period for Outstanding Vested Stock Options.  The Covered Employee (or the Covered Employee’s estate, as applicable) shall have twelve (12) months (in the case of the Covered Employee’s Disability) or eighteen (18) months (in the case of the Covered Employee’s death) following the date of the Covered Employee’s Death/Disability Termination in which to exercise the outstanding and vested stock options held by the Covered Employee as of the date of the Covered Employee’s Death/Disability Termination that are granted on or after the Effective Date (including, but not limited to, any such stock options that become vested in accordance with Section 4.3.3); provided, however, that in no event will the Covered Employee’s stock options be permitted to be exercised beyond their original maximum term to expiration.

4.4.Retirement.  If a Covered Employee’s employment with the Company is terminated due to Retirement, then, subject to the Covered Employee’s compliance with Section 5, the Covered Employee shall receive the following Severance Benefits from the Company:

4.4.1.Full Bonus.  To the extent not already paid to the Covered Employee, the Covered Employee will additionally be eligible to receive the Full Bonus, which shall be paid, less applicable tax withholdings, in a lump sum cash payment concurrently with the annual cash bonus payments to other similarly-situated employees, provided, that no payment shall be made prior to the Initial Payment Date, but that such payment shall in any event be made prior to March 15 of the year following the year of the Covered Employee's termination.

4.4.2.Pro-Rated Bonus.  The Covered Employee will be eligible to receive the Pro-Rated Bonus, less applicable tax withholdings, which shall be payable to the Covered Employee in a 

7

 

lump sum concurrently with the annual cash bonus payments to other similarly-situated employees under the Annual Bonus Program,  provided, that no payment shall be made prior to the Initial Payment Date but that such payment shall in any event be made prior to March 15 of the year following the year of the Covered Employee's termination.  

4.4.3.Post-Termination Exercisability Period for Outstanding Vested Stock Options.  The Covered Employee shall have three (3) months following the date of the Covered Employee’s Retirement in which to exercise the outstanding and vested stock options held by the Covered Employee as of the date of the Covered Employee’s Retirement that are granted on or after the Effective Date; provided, however, that in no event will the Covered Employee’s stock options be permitted to be exercised beyond their original maximum term to expiration.

5.Conditions to Receipt of Severance. 

5.1.Release Agreement.  As a condition to receiving the Severance Benefits set forth in Section 4, a Covered Employee must sign a release of all claims in favor of the Company and its subsidiaries and affiliates (the “Release”) in such form as may be provided by the Company.  The Release must become effective in accordance with its terms, which must occur in no event more than sixty (60) days following the applicable Termination Date.  In no event shall payment of any benefits under the Plan be made prior to a Covered Employee’s Termination Date or prior to the effective date of the Release.  If the Company determines that any payments or benefits provided under the Plan constitute “deferred compensation” under Section 409A, and the Covered Employee’s Termination Date occurs at a time during the calendar year when the Release could become effective in the calendar year following the calendar year in which the Covered Employee’s “separation from service” within the meaning of Section 409A of the Code and the final regulations and any guidance promulgated thereunder (“Section 409A”) occurs, then regardless of when the Release is returned to the Company and becomes effective, the Release will not be deemed effective any earlier than the latest permitted effective date; provided, that except to the extent that payments may be delayed in accordance with Section 8, on the first regular payroll date following the effective date of a Covered Employee’s Release, the Company shall (i) pay the Covered Employee a lump sum amount equal to the sum of the Severance Benefits that the Covered Employee would otherwise have received through such payroll date but for the delay in payment related to the effectiveness of the Release and (ii) commence paying the balance, if any, of the Severance Benefits in accordance with the applicable payment schedule.

5.2.Other Requirements.  A Covered Employee’s receipt of Severance Benefits pursuant to Section 4 will be subject to such Covered Employee continued material compliance with the terms of the Release, the Participation Agreement, the non-disparagement provisions of a separation agreement provided by the Company, and any confidential information agreement, proprietary information and inventions agreement and any other agreement between the Covered Employee and the Company.  Severance Benefits under this Plan shall terminate immediately for a Covered Employee if such Covered Employee is in material violation, at any time, of any legal or contractual obligation owed to the Company. 

5.3.Section 280G.  Any provision of the Plan to the contrary notwithstanding, if any payment or benefit a Covered Employee would receive from the Company and its subsidiaries or an acquiror pursuant to the Plan or otherwise (a “Payment”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment will be equal to the Higher Amount (defined below).  The “Higher Amount” will be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable 

8

 

marginal rate), results in Covered Employee’s receipt, on an after-tax basis, of the greater economic benefit notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.  If a reduction in payments or benefits constituting “parachute payments” within the meaning of Section 280G of the Code is necessary so that the Payment equals the Higher Amount, reduction will occur in the manner that results in the greatest economic benefit for a Covered Employee and, to the extent applicable, complies with Section 409A.  In no event will the Company, any subsidiary or any stockholder be liable to any Covered Employee for any amounts not paid as a result of the operation of this Section 5.3.  The Company will use commercially reasonable efforts to cause the accounting or law firm engaged to make the determinations hereunder to provide its calculations, together with detailed supporting documentation, to a Covered Employee and the Company within 15 calendar days after the date on which such Covered Employee’s right to a Payment is triggered (if requested at that time by such Covered Employee or the Company) or such other time as requested by such Covered Employee or the Company.  

6.Non-Duplication of Benefits.  Notwithstanding any other provision in the Plan to the contrary, the Severance Benefits provided to a Covered Employee are intended to be and are exclusive and in lieu of any other change in control severance benefits or payments to which such Covered Employee may otherwise be entitled, either at law, tort, or contract, in equity, or under the Plan, in the event of any termination of such Covered Employee’s employment.  The Covered Employee will be entitled to no change in control severance benefits or payments upon a termination of employment that constitutes a Covered Termination, Death/Disability Termination or Retirement other than those benefits expressly set forth herein and those benefits required to be provided by applicable law or as negotiated in accordance with applicable law (including any severance benefits that may be included in a severance agreement, employment agreement or similar contract between the Company or a subsidiary of the Company and the Covered Employee).  Notwithstanding the foregoing, if a Covered Employee is entitled to any benefits other than the benefits under the Plan by operation of applicable law or as negotiated in accordance with applicable law, such Covered Employee’s benefits under the Plan shall be provided only to the extent more favorable than such other arrangement.  The Administrator, in its sole and absolute discretion, shall have the authority to reduce or otherwise adjust a Covered Employee’s benefits under the Plan, in whole or in part, by any other severance benefits, pay and benefits in lieu of notice, or other similar benefits payable to such Covered Employee under the Plan that become payable in connection with the Covered Employee’s termination of employment pursuant to (i) any applicable legal requirement, including the Worker Adjustment and Retraining Notification Act (the “WARN Act”), the California Plant Closing Act or any other similar state law, or (ii) any policy or practice of the Company providing for the Covered Employee to remain on payroll for a limited period of time after being given notice of termination.  The benefits provided under the Plan are intended to satisfy, in whole or in part, any and all statutory obligations of the Company that may arise out of a Covered Employee’s termination of employment, and the Administrator shall so construe and implement the terms of the Plan.

7.Clawback; Recovery.  All payments and severance benefits provided under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company’s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law.  In addition, the Administrator may impose such other clawback, recovery or recoupment provisions as the Administrator determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of common stock of the Company or other cash or property upon the occurrence of a termination of employment for Cause.  No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for Good Reason, constructive termination, or any similar term under any plan of or agreement with the Company.  

9

 

8.Section 409A.  Notwithstanding anything to the contrary in the Plan, no severance payments or benefits will become payable until the Covered Employee has incurred a “separation from service” within the meaning of Section 409A.  Further, if some or all of the Covered Employee’s Severance Benefits are subject to Section 409A and such Covered Employee is a “specified employee” within the meaning of Section 409A at the time of such Covered Employee’s separation from service (other than due to death), then such Severance Benefits otherwise due to such Covered Employee on or within the six-month period following such Covered Employee’s separation from service will accrue during such six-month period and will become payable in a lump sum payment (less applicable withholding taxes) on the date six months and one day following the date of the Covered Employee’s separation from service if necessary to avoid adverse taxation under Section 409A.  All subsequent payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.  Notwithstanding anything herein to the contrary, if the Covered Employee dies following such Covered Employee’s separation from service but prior to the six-month anniversary of such Covered Employee’s date of separation, then any payments delayed in accordance with this paragraph will be payable in a lump sum (less applicable withholding taxes) to the Covered Employee’s estate as soon as administratively practicable after the date of such Covered Employee’s death and all other benefits will be payable in accordance with the payment schedule applicable to each payment or benefit.  Each payment and benefit payable under the Plan is intended to constitute a separate payment for purposes of Section 409A.  It is the intent of this Plan to comply with or be exempt from the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply.  Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under the Plan comply with Section 409A, and in no event shall the Company or any of its representatives be liable for all or any portion of any taxes, penalties, interest, or other expenses that may be incurred by the Covered Employee on account of non-compliance with Section 409A.

9.Withholding.  The Company will withhold from any Severance Benefits all federal, state, local and other taxes required to be withheld therefrom and any other required payroll deductions. 

10.Administration.  The Plan will be administered and interpreted by the Administrator (in the Administrator’s sole and absolute discretion).  The Administrator is the “named fiduciary” of the Plan for purposes of ERISA and will be subject to the fiduciary standards of ERISA when acting in such capacity.  Any decision made or other action taken by the Administrator with respect to the Plan, and any interpretation by the Administrator of any term or condition of the Plan, or any related document, will be conclusive and binding on all persons and be given the maximum possible deference allowed by law.  Any decision made or other action taken by the Administrator with respect to the Plan, and any interpretation by the Administrator of any term or condition of the Plan, or any related document that (i) does not affect the benefits payable under the Plan shall not be subject to review unless found to be arbitrary and capricious or (ii) does affect the benefits payable under the Plan shall not be subject to review unless found to be unreasonable or not to have been made in good faith.  

11.Amendment or Termination.  The Company, by action of the Administrator, reserves the right to amend or terminate the Plan at any time, without advance notice to any Covered Employee and without regard to the effect of the amendment or termination on any Covered Employee or on any other individual.  Any amendment or termination of the Plan will be in writing.  Notwithstanding the foregoing, a Covered Employee’s rights to receive payments and benefits pursuant to this Plan under an effective Participation Agreement may not be adversely affected, without the Covered Employee’s written consent, by an amendment or termination of this Plan.

12.Claims Procedure.  Claims for benefits under the Plan shall be administered in accordance with Section 503 of ERISA and the Department of Labor Regulations thereunder.  Any employee or other 

10

 

person who believes they are entitled to any payment under the Plan (a “claimant”) may submit a claim in writing to the Administrator within 90 days of the earlier of (i) the date the claimant learned the amount of such claimant’s severance benefits under the Plan or (ii) the date the claimant learned that they will not be entitled to any benefits under the Plan.  In determining claims for benefits, the Administrator or its delegate has the authority to interpret the Plan, to resolve ambiguities, to make factual determinations, and to resolve questions relating to eligibility for and amount of benefits.  If the claim is denied (in full or in part), the claimant will be provided a written notice explaining the specific reasons for the denial and referring to the provisions of the Plan on which the denial is based.  The notice will also describe any additional information or material that the Administrator needs to complete the review and an explanation of why such information or material is necessary and the Plan’s procedures for appealing the denial (including a statement of the applicant’s right to bring a civil action under Section 502(a) of ERISA following a denial on review of the claim, as described below).  The denial notice will be provided within 90 days after the claim is received.  If special circumstances require an extension of time (up to 90 days), written notice of the extension will be given to the claimant (or representative) within the initial 90-day period.  This notice of extension will indicate the special circumstances requiring the extension of time and the date by which the Administrator expects to render its decision on the claim.  If the extension is provided due to a claimant’s failure to provide sufficient information, the time frame for rendering the decision will be tolled from the date the notification is sent to the claimant about the failure to the date on which the claimant responds to the request for additional information.  The Administrator has delegated the claims review responsibility to the Company’s Chief Financial Officer or such other individual designated by the Administrator, except in the case of a claim filed by or on behalf of the Company’s Chief Financial Officer or such other individual designated by the Administrator, in which case, the claim will be reviewed by the Company’s Chief Executive Officer. 

13.Appeal Procedure.  If the claimant’s claim is denied, the claimant (or such claimant’s authorized representative) may apply in writing to an appeals official appointed by the Administrator (which may be a person, committee or other entity) for a review of the decision denying the claim.  Review must be requested within 60 days following the date the claimant received the written notice of a claim denial or else the claimant will lose the right to such review.  A request for review must set forth all the grounds on which such request is based, all facts in support of the request, and any other matters that the claimant feels are pertinent.  In connection with the request for review, the claimant (or representative) has the right to review and obtain copies of all documents and other information relevant to the claim, upon request and at no charge, and to submit written comments, documents, records and other information relating to such claimant’s claim.  The review shall take into account all comments, documents, records and other information submitted by the claimant (or representative) relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination.  The appeals official will provide written notice of its decision on review within 60 days after it receives a review request.  If special circumstances require an extension of time (up to 60 days), written notice of the extension will be given to the claimant (or representative) within the initial 60-day period.  This notice of extension will indicate the special circumstances requiring the extension of time and the date by which the appeals official expects to render its decision.  If the extension is provided due to a claimant’s failure to provide sufficient information, the time frame for rendering the decision on review is tolled from the date the notification is sent to the claimant about the failure to the date on which the claimant responds to the request for additional information.  If the claim is denied (in full or in part) upon review, the claimant will be provided a written notice explaining the specific reasons for the denial and referring to the provisions of the Plan on which the denial is based.  The notice shall also include a statement that the claimant will be provided, upon request and free of charge, reasonable access to, and copies of, all documents and other information relevant to the claim and a statement regarding the claimant’s right to bring an action under Section 502(a) of ERISA.  The Administrator has delegated the appeals review responsibility to the Company’s Chief Financial Officer, except in the case of an appeal filed by or on behalf of the Company’s Chief Financial Officer, in which case, the appeal will be reviewed by the Company’s Chief Executive Officer. 

11

 

14.Arbitration.  No arbitration proceeding shall be brought to recover benefits under the Plan until the claims procedures described in Sections 12 and 13 have been exhausted and the Plan benefits requested have been denied in whole or in part.  Notwithstanding any other provision of the Plan, to ensure the timely and economical resolution of disputes, all disputes, claims, or causes of action arising from or relating to the enforcement, breach, performance or interpretation of this Plan will be resolved to the fullest extent permitted by law by final, binding and confidential arbitration, by a single arbitrator, in the State of Texas, conducted by JAMS, Inc. (“JAMS”) under the then-applicable JAMS rules (available at the following web address: https://www.jamsadr.com/rules-employment).  By agreeing to this arbitration procedure, each Covered Employee and the Company waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding.  Covered Employees will have the right to be represented by legal counsel at any arbitration proceeding.  In addition, all claims, disputes, or causes of action under this Section 14, whether by a Covered Employee or the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member in any purported class or representative proceeding, nor joined or consolidated with the claims of any other person or entity.  The arbitrator may not consolidate the claims of more than one person or entity, and may not preside over any form of representative or class proceeding.  To the extent that the preceding sentences regarding class claims or proceedings are found to violate applicable law or are otherwise found unenforceable, any claim(s) alleged or brought on behalf of a class shall proceed in a court of law rather than by arbitration.  The arbitrator shall:  (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision, to include the arbitrator’s essential findings and conclusions and a statement of the award.  The arbitrator shall be authorized to award any or all remedies that a Covered Employee or the Company would be entitled to seek in a court of law.  The Company shall pay all JAMS’ arbitration fees in excess of the amount of court fees that would be required of a Covered Employee if the dispute were decided in a court of law.  Nothing in this paragraph is intended to prevent either a Covered Employee or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration.  Any awards or orders in such arbitrations may be entered and enforced as judgments in the federal and state courts of any competent jurisdiction.  Any arbitration must be commenced within one year after the Covered Employee’s receipt of notification that their appeal was denied.  The foregoing provisions shall apply to the extent consistent with and permitted by ERISA.

15.Source of Payments.  All severance benefits will be paid in cash from the general funds of the Company; no separate fund will be established under the Plan, and the Plan will have no assets.  No right of any person to receive any payment under the Plan will be any greater than the right of any other general unsecured creditor of the Company. 

16.Inalienability.  In no event may any current or former employee of the Company or any of its subsidiaries or affiliates sell, transfer, anticipate, assign or otherwise dispose of any right or interest under the Plan.  At no time will any such right or interest be subject to the claims of creditors nor liable to attachment, execution or other legal process. 

17.No Enlargement of Employment Rights.  Neither the establishment nor maintenance of the Plan, any amendment of the Plan, nor the making of any benefit payment hereunder, will be construed to confer upon any individual any right to be continued as an employee of the Company.  The Company expressly reserves the right to discharge any of its employees at any time, with or without cause.  However, as described in the Plan, a Covered Employee may be entitled to benefits under the Plan depending upon the circumstances of such Covered Employee’s termination of employment. 

18.Successors.  Any successor to the Company of all or substantially all of the Company’s business or assets (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) will assume the obligations under the Plan and agree expressly to perform the obligations 

12

 

under the Plan in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession.  For all purposes under the Plan, the term “Company” will include any successor to the Company’s business or assets which become bound by the terms of the Plan by operation of law, or otherwise. 

19.Applicable Law.  The provisions of the Plan will be construed, administered and enforced in accordance with ERISA and, to the extent applicable, the internal substantive laws of the State of Texas (except its conflict of laws provisions). 

20.Severability.  If any provision of the Plan is held invalid or unenforceable, its invalidity or unenforceability will not affect any other provision of the Plan, and the Plan will be construed and enforced as if such provision had not been included. 

21.Headings.  Headings in this Plan document are for purposes of reference only and will not limit or otherwise affect the meaning hereof. 

22.Additional Information.

	
 
	
 
	
 

	
Plan Name:
	
  
	
Vital Farms, Inc. Change in Control Severance Plan

	
 
	
 

	
Plan Sponsor:
	
  
	
Vital Farms, Inc.

	
 
	
 

	
 
	
 

	
Plan Year:
	
  
	
Company’s fiscal year 

	
 
	
 

	
Plan Administrator:
	
  
	
Vital Farms, Inc.

	
 
	
  
	
Attention: Administrator of the Vital Farms, Inc. Change in Control Severance Plan

	
 
	
  
	
 

	
 
	
  
	
 

	
 
	
  
	
 

	
 
	
 

	
Agent for Service of
	
  
	
Vital Farms, Inc.

	
Legal Process:
	
  
	
Attention: Administrator of the Vital Farms, Inc. Change in Control Severance Plan

	
 
	
  
	
 

	
 
	
  
	
Service of process may also be made upon the Administrator.

	
 
	
 

	
Type of Plan:
	
  
	
Severance Plan/Employee Welfare Benefit Plan

	
 
	
 

	
Plan Costs:
	
  
	
The cost of the Plan is paid by the Company.

 

23.Statement of ERISA Rights. 

As a Covered Employee under the Plan, you have certain rights and protections under ERISA: 

(a)You may examine (without charge) all Plan documents, including any amendments and copies of all documents filed with the U.S. Department of Labor.  These documents are available for your review in the office of the Company’s Chief Financial Officer. 

13

 

(b)You may obtain copies of all Plan documents and other Plan information upon written request to the Administrator.  A reasonable charge may be made for such copies. 

In addition to creating rights for Covered Employees, ERISA imposes duties upon the people who are responsible for the operation of the Plan.  The people who operate the Plan (called “fiduciaries”) have a duty to do so prudently and in the interests of you and the other Covered Employees.  No one, including the Company or any other person, may fire you or otherwise discriminate against you in any way to prevent you from obtaining a benefit under the Plan or exercising your rights under ERISA.  If your claim for a severance benefit is denied, in whole or in part, you have a right to know why it was denied, to obtain copies of documents relating to the decision without charge, and to appeal any denial, all within certain time schedules.  The claim review procedure is explained in Sections 12 and 13, above. 

Under ERISA, there are steps you can take to enforce the above rights.  For instance, if you request a copy of Plan documents and do not receive them within 30 days, you may file suit in a federal court.  In such a case, the court may require the Administrator to provide the materials and to pay you up to $110 a day until you receive the materials, unless the materials were not sent because of reasons beyond the control of the Administrator.  If you have a claim which is denied or ignored, in whole or in part, you may file suit in a federal court.  If it should happen that you are discriminated against for asserting your rights, you may seek assistance from the U.S. Department of Labor, or you may file suit in a federal court.  The court will decide who should pay court costs and legal fees.  If you are successful, the court may order the person you have sued to pay these costs and fees.  If you lose, the court may order you to pay these costs and fees, for example, if it finds your claim is frivolous.

If you have any questions regarding the Plan, please contact the Administrator.  If you have any questions about this statement or about your rights under ERISA, you may contact the nearest office of the Employee Benefits Security Administration, U.S. Department of Labor, listed in your telephone directory, or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue, N.W. Washington, D.C. 20210.  You may also obtain certain publications about your rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration at 1-866-444-3272. 

14

 

 

Appendix A

 

VITAL FARMS, Inc.

Change in Control Severance Plan

 

Participation Agreement

Vital Farms, Inc. (the “Company”) is pleased to inform you, [name], that you have been selected to participate in the Company’s Change in Control Severance Plan (the “Plan”) as a Covered Employee.  A copy of the Plan was delivered to you with this Participation Agreement.  Your participation in the Plan is subject to all of the terms and conditions of the Plan.  The capitalized terms used but not defined herein will have the meanings ascribed to them in the Plan.

In order to become a Covered Employee under the Plan, you must complete and sign this Participation Agreement and return it to [name] no later than [date].

The Plan describes in detail certain circumstances under which you may become eligible for Severance Benefits and the amount of those benefits.  As described more fully in the Plan, you may become eligible for certain Severance Benefits if you experience a Covered Termination or Death/Disability Termination or if your employment with the Company is terminated due to Retirement. 

If you become eligible for Standard Severance Benefits under Section 4.1 of the Plan, then subject to the terms and conditions of the Plan, you will receive:

		
	
Base Salary
	
[•] months

	
Full Bonus
	
 

	
Post-Termination Exercise Period of Vested Stock Options  Granted on or After the Effective Date
	
3 months

	
COBRA Premiums
	
[•] months

 

If you become eligible for CIC Severance Benefits under Section 4.2 of the Plan, then subject to the terms and conditions of the Plan, you will receive:

		
	
Base Salary
	
[•] months

	
[Target Bonus]
	
 

	
Full Bonus
	
 

	
Pro-Rated Bonus
	
 

	
Accelerated Equity Vesting
	
100%

	
Post-Termination Exercise Period of Vested Stock Options Granted on or After the Effective Date
	
3 months

	
COBRA Premiums
	
[•]months

 

If you experience a Death/Disability Termination or if your employment with the Company is terminated due to Retirement, you will receive the Severance Benefits under Section 4.3 or Section 4.4, respectively, of the Plan, subject to the terms and conditions of the Plan.

In order to receive any Severance Benefits for which you otherwise become eligible under the Plan, you must sign and deliver to the Company the Release, which must have become effective and irrevocable, and otherwise comply with the requirements under Section 5 of the Plan.

In accordance with Section 6 of the Plan, the benefits, if any, provided under the Plan are intended to be the exclusive benefits for you related to your termination of employment in connection with a change 

in control of the Company and will supersede and replace any change in control severance benefits to which you otherwise would eligible to participate in any other Company change in control severance policy, plan, agreement or other arrangement (whether or not subject to ERISA). 

By your signature below, you and the Company agree that your participation in the Plan is governed by this Participation Agreement and the provisions of the Plan.  Your signature below confirms that: (i) you have received a copy of the Plan; (ii) you have carefully read this Participation Agreement and the Plan and you acknowledge and agree to its terms, including, but not limited to, Section 6 of the Plan; and (iii) decisions and determinations by the Administrator under the Plan will be final and binding on you and your successors.

 

					
	
VITAL FARMS, INC.
	
 
	
COVERED EMPLOYEE

	
 
	
 
	
 

	
Signature
	
 
	
Signature

	
 
	
 
	
 
	
 
	
 

	
Name:
	
 
	
 
	
Name:
	
 

	
 
	
 
	
 
	
 
	
 

	
Title:
	
 
	
 
	
Title:
	
 

	
 
	
 
	
 
	
 
	
 

	
Date:
	
 
	
 
	
Date:
	
 

 

Attachment: Vital Farms, Inc. Change in Control Severance Plan

 

[Signature Page to Vital Farms, Inc. Change in Control Severance Plan]ex_348185.htm

Exhibit 10.1

CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY "[***]," HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

 

	AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT	 	1. CONTRACT ID CODE	 	PAGE OF PAGES
	 	 	 	 	1 	4
	
			2. AMENDMENT/MODIFICATION NO.

			P00023

				
			3. EFFECTIVE DATE

			01/14/2022

				
			4. REQUISITION/PURCHASE REQ. NO.

			OS288262

				
			 5. PROJECT NO. (if applicable)

			ASPR-22-00229

			
	
			6. ISSUED BY

				CODE  	HHS/OS/ASPR/BARDA	7. ADMINISTERED BY (if other than Item 6)      	 CODE  	ASPR-BARDA02
	
			HHS/OS/ASPR/BARDA

			330 Independence Ave., S.W.

			Room 640-G

			Washington DC 20201 

				 	
			 

			ASPR-BARDA

			330 Independence Ave., S.W., Rm G640

			Washington DC 20201

				 
	
			8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)

			 

			SIGA TECHNOLOGIES, INC. 1385150

			Attn: Kady Honeychurch

			SIGA TECHNOLOGIES, INC.         35  E  6

			35 E 62ND ST

			NEW YORK NY 100658014

				 	(x)	9A. AMENDMENT OF SOLICITATION NO.
	 	 	 
	 	 	9B. DATED (SEE ITEM 11)
	 	x	
			10A. MODIFICATION OF CONTRACT/ORDER NO.

			HHSO100201100023C

			
	
			CODE  1385150

				FACILITY CODE	 	
			10B. DATED (SEE ITEM 13)

			06/01/2011

				 
	
			11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

				 
	
			☐ The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers              ☐ is extended.      ☐ is not extended.

			Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods: (a) By completing Items 8 and 15, and returning ______ copies of the amendment, (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

			
	
			12. ACCOUNTING AND APPROPRIATION DATA (if required)

			See Schedule

				Net Increase:         $219,872.37	 
	
			13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

				 
	
			CHECK ONE

				
			A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

			
	 	 
	 	
			B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

			 

			
	X	
			C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

			52.243-2   Changes – Cost Reimbursement, Alt V

			
	 	
			D. OTHER (Specify type of modification and authority) 

			 

			
	
			E. IMPORTANT:    Contractor    ☐ is not.    ☒ is required to sign this document and return 1 copies to the issuing office.

				 
	
			14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

			
	
			Tax ID Number: 13-3864870

			
	
			DUNS Number: 932651516

			
	
			1.         The purpose of this cost-reimbursement type modification P00023 is to provide supplemental funding in the amount of $219,872.37 to fund budget shortages for CLIN 00005 pursuant to indirect rate redetermination and in accordance with accepted contractor revised CLIN 0005 Shortage Table received 01/14/2022.

			2.         The total contract amount funded under this contract (inclusive of fixed fee) is increased by $219,872.37 from $[***] to $[***]. For further provisions on funding, see the Limitations of Costs clause in PART II Section I, Clauses.

			3.         The overall revised contract value $[***].

			4.         the Contractor is hereby notified that mandatory U.S. Treasury Invoice Processing

			
	
			Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

			
	
			15A. NAME AND TITLE OF SIGNER (Type or print)

			Dennis E. Hruby, CSO & EVP

				
			16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

			JOHN K. WARNER

			
	
			15B. CONTRACTOR/OFFEROR

			/s/ Dennis E. Hruby

			(Signature of person authorized to sign)

				15C. DATE SIGNED

			15 Feb 2022	16B. UNITED STATES OF AMERICA

			/s/ John K. Warner

			(Signature of Contracting Officer)	16C. DATE SIGNED

			02/03/2022
	
			Previous edition unusable

				 	STANDARD FORM 30 (REV. 11-2016)

			Prescribed by GSA FAR (48 CFR) 53.243

 

 

 

 

	
			CONTINUATION SHEET

				
			REFERENCE NO. OF DOCUMENT BEING CONTINUED

			HHSO100201100023C/P00023

				
			 

				PAGE OF
	 	 	
			 

				
			 

				2	4
	
			NAME OF OFFEROR OR CONTRACTOR

			SIGA TECHNOLOGIES, INC. 1385150

			
	
			ITEM NO

			(A)

				
			SUPPLIES/SERVICES

			(B)

				
			QUANTITY

			(C)

				
			UNIT

			(D)

				
			UNIT PRICE

			(E)

				
			AMOUNT

			(F)

			
	 	
			Platform (IPP) invoice submittal system will be incorporated at yet an undetermined date into this contract upon formal authorization of HHS IPP clause.

			 

				 	 	 	 
	 	
			(See block 14 continuation sheet).

				 	 	 	 
	 	
			 

			Discount Terms: HHS NET 30P

			Period of Performance: 09/01/2008 to 02/08/2024

				 	 	 	 
	 	
			 

			Change Item 7 to read as follows (amount shown is the obligated amount):

				 	 	 	 
	
			7

				
			 

			ASPR-17-00856 Exercise of CLINS 3 4 5 7 8

				 	 	 	
			219,872.37

			
	 	
			 

			Accounting Info:

			2017.1992017.25103 Appr. Yr.: 2017 CAN: 1992017  Object Class: 25103

			Funded: $0.00

				 	 	 	 
	 	
			 

			Accounting Info:

			2019.1992019.25106 Appr. Yr.: 2019 CAN: 1992019  Object Class: 25106

			Funded: $0.00

				 	 	 	 
	 	
			 

			Accounting Info:

			2019.1992018.25106 Appr. Yr.: 2019 CAN: 1992018  Object Class: 25106

			Funded: $0.00

				 	 	 	 
	 	
			 

			Accounting Info:

			2022.1992022.25106 Appr. Yr.: 2022 CAN: 1992022  Object Class: 25106

			Funded: $219,872.37

				 	 	 	 
	 	
			 

			ASPR-22-00229 CLIN 0005 Phase I - IV DP Stability: funding per re-determined indirect rates

			         Original funding: $959,798.00 + Mod 23 funding $219,872.37 = Revised funding $1,179,670.37

				 	 	 	 
	 	
			 

			PSC: AN13 NAICS: 541711 COR is Annie Lu, Ph.D.  (202) 604-5814, Xi.Lu@hhs.gov

				 	 	 	 
	NSN 7540-01-152-8067	 	 	 	
			OPTIONAL FORM 336 (4-86)

			Sponsored by GSA

			FAR (48 CFR) 53.110

			

 

 

 

 

	
			Contract No. HHSO100201100023C

				
			Continuation Sheet Block 14

				
			Page 3 of 4

			
	
			Mod P00023

				 	 

 

5. ARTICLE B.4 ADVANCE UNDERSTANDINGS

 

The following final indirect cost rates incorporated under modification P00019 remain in effect and apply to the following item 5 and 6 supplemental funding:

 

	 	
			●

				
			G&A: [***]

			

 

	 	
			●

				
			Overhead: [***]

			

 

	 	
			●

				
			Fringe: [***]

			

 

6. ARTICLE 4.B ADVANCE UNDERSTANDINGS, subsection j. Subcontracts/Consultant Agreements is modified as follows:

 

	
			Change From

				
			[***]

			
	
			CLIN

				
			Scope

				
			[***]

				
			[***]

				
			[***]

				
			[***]

			
	
			0005

				
			Stability and Storage

				
			[***]

				
			[***]

				
			[***]

				
			[***]

			
	 	 	 	 	 	 
	
			Change To

				
			[***]

			
	
			CLIN

				
			Scope

				
			[***]

				
			[***]

				
			[***]

				
			[***]

			
	
			0005

				
			Stability and Storage

				
			[***]

				
			[***]

				
			[***]

				
			[***]

			

 

7. Article B.5 – Option(s)  The pricing (to include the subcontract by Options Period Chart) is updated as follows (adjustments reflect API/Kleptose credit in the amount of -$[***]).

 

ARTICLE B.5 – OPTION(S)

 

	
			Change From

				
			[***]

			
	
			CLINS

				
			Specified Time

				
			Date

				Description of Work	
			[***]

				
			[***]

				
			[***]

			
	
			CLIN 0005

				
			IV Option 4

				
			12/30/2020-12/30/2020

				Scale-Up, Process Validation and DP Stability	
			[***]

				
			[***]

				
			[***]

			
	 	 	 	 	 	 	 
	
			Change To

				
			[***]

			
	
			CLINS

				
			Specified Time

				
			Date

				
			Description of Work

				
			[***]

				
			[***]

				
			[***]

			
	
			CLIN 0005

				
			IV Option 4

				
			02/08/2024-02/08/2024

				
			Scale-Up, Process Validation and DP Stability

				
			[***]

				
			[***]

				
			[***]

			

 

8. ARTICLE C.2. REPORTING REQUIREMENTS, subsection b. Other Reports/Deliverables,

10. FDA Communications, Correspondence and Meeting Summaries is amended as follows:

 

a)  Within two (2) calendar days of the submission of any communication to the FDA, send copies of the communication to the Project Officer (PO):

 

b)  Within thirty (30) calendar days of receiving correspondence or meeting with the FDA, submit copies of correspondence or meeting minutes/summaries to the PO.

 

c)  No mention of BARDA involvement in FDA meeting, BARDA review prior to FDA submissions, notification of FDA IRs to BARDA of correspondences in real time.

FDA Meeting Notification

 

 

 

	
			Contract No. HHSO100201100023C

				
			Continuation Sheet Block 14

				
			Page 4 of 4

			
	
			Mod P00023

				 	 

 

a)  No later than 10 business days prior to the scheduled meeting, or as soon as meeting is scheduled.

 

b)  Contractor shall forward the dates and times of any meeting with the FDA to BARDA and arrange for appropriate BARDA staff to attend the FDA meetings.

 

FDA correspondence and meeting minute

Within three (3) calendar days of receiving correspondence from the FDA

 

FDA Submissions

a)  At least fifteen (15) business days prior to submission to the FDA, or as soon as available.

 

b)   Contractor shall provide BARDA the opportunity to review and comment upon all draft regulatory documents before submission to the FDA. Contractor shall provide BARDA with an electronic copy of the final FDA submission.

 

c)  Contractor shall address in writing all concerns raised by BARDA before FDA submission

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]